Table 5.
Multivariate analysis for mortality within 5 years after HTX
| Variable | HR | 95% CI |
|---|---|---|
| FEV1/FVC <0.70 (in total) | 4.77 | 2.76, 8.22 |
| Recipient age (>60.0 years) | 1.62 | 0.95, 2.73 |
| Recipient body mass index (>25.0 kg/m2) | 1.16 | 0.73, 1.85 |
| Coronary artery disease (in total) | 1.36 | 0.59, 3.11 |
| Dyslipidemia (in total) | 0.93 | 0.49, 1.77 |
| History of smoking (in total) | 0.69 | 0.38, 1.28 |
| Ischemic CMP* (in total) | 0.50 | 0.21, 1.18 |
| Nonischemic CMP* (in total) | 0.36 | 0.20, 0.66 |
| Ischemic time (≥240 minutes) | 0.72 | 0.46, 1.12 |
Note:
*
The principal diagnosis for HTX.
Abbreviations: CMP, cardiomyopathy; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; FEV1/FCV, Tiffeneau index; HTX, heart transplantation.